AMN082
AMN082
AMN082 (pronounced as A-M-N-zero-eight-two) is a selective metabotropic glutamate receptor 7 (mGluR7) allosteric agonist. It is a chemical compound used primarily in scientific research.
Etymology
The term AMN082 is an acronym derived from the names of the scientists who first synthesized the compound: A for AstraZeneca, M for Merck, and N for Novartis. The number 082 is an arbitrary number assigned for identification purposes.
Usage
AMN082 has been used in various research studies to understand the role of mGluR7 in the central nervous system. It is known to penetrate the blood-brain barrier, which makes it a useful tool in neuroscience research.
Related Terms
- Allosteric agonist: A type of drug that modulates a receptor's activity by binding to a site other than the active site.
- Metabotropic glutamate receptor 7 (mGluR7): A type of receptor in the brain that plays a role in neurotransmission.
- Blood-brain barrier: A highly selective semipermeable border that separates the circulating blood from the brain and extracellular fluid in the central nervous system.
See Also
External links
- Medical encyclopedia article on AMN082
- Wikipedia's article - AMN082
This WikiMD dictionary article is a stub. You can help make it a full article.
Languages: - East Asian
中文,
日本,
한국어,
South Asian
हिन्दी,
Urdu,
বাংলা,
తెలుగు,
தமிழ்,
ಕನ್ನಡ,
Southeast Asian
Indonesian,
Vietnamese,
Thai,
မြန်မာဘာသာ,
European
español,
Deutsch,
français,
русский,
português do Brasil,
Italian,
polski